Atrayee Basu Mallick, MD, talks about the patient type and setting where vemurafenib has been added to the NCCN guidelines for metastatic colorectal cancer (mCRC) patients at Annual Meeting 2018
The addition of vemurafenib to the NCCN guidelines for mCRC
